Abstract
Baculoviruses have shown great potential as gene delivery vectors in mammals, although their effectiveness in transferring genes varies across different cell lines. A widely employed strategy to improve transduction efficiency is the pseudotyping of viral vectors. In this study, we aimed to develop a stable Sf9 insect cell line that inducibly expresses the G-protein of the vesicular stomatitis virus to pseudotype budded baculoviruses. It was obtained by inserting the VSV-G gene under the control of the very strong and infection-inducible pXXL promoter and was subsequently diluted to establish oligoclonal lines, which were selected by the fusogenic properties of VSV-G and its expression levels in infected cells and purified budded virions. Next, to enhance the performance of the cell line, the infection conditions under which functional pseudotyped baculoviruses are obtained were optimized. Finally, different baculoviruses were pseudotyped and the expression of the transgene was quantified in mammalian cells of diverse origins using flow cytometry. The transduction efficiency of pseudotyped baculovirus consistently increased across all tested mammalian cell lines compared with control viruses. These findings demonstrate the feasibility and advantages of improving gene delivery performance without the need to insert the pseudotyping gene into the baculoviral genomes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The datasets generated during the current study are available from the corresponding author on reasonable request.
References
van Oers MM. Opportunities and challenges for the baculovirus expression system. J Invertebr Pathol. 2011;107:S3–15.
Condreay JP, Kost TA. Baculovirus expression vectors for insect and mammalian cells. Curr Drug Targets. 2007;8:1126–31.
van Oers MM, Pijlman GP, Vlak JM. Thirty years of baculovirus-insect cell protein expression: from dark horse to mainstream technology. J Gen Virol. 2015;96:6–23.
Tani H, Morikawa S, Matsuura Y. Development and applications of VSV vectors based on cell tropism. Front Microbiol. 2011;2:272.
Kaikkonen MU, Räty JK, Airenne KJ, Wirth T, Heikura T, Ylä-Herttuala S. Truncated vesicular stomatitis virus G protein improves baculovirus transduction efficiency in vitro and in vivo. Gene Ther. 2005;13:304.
Chen ST, Iida A, Guo L, Friedmann T, Yee JK. Generation of packaging cell lines for pseudotyped retroviral vectors of the G protein of vesicular stomatitis virus by using a modified tetracycline inducible system. Proc Natl Acad Sci USA. 1996;93:10057–62.
López MG, Alfonso V, Carrillo E, Taboga O. Trans-complementation of polyhedrin by a stably transformed Sf9 insect cell line allows occ- baculovirus occlusion and larval per os infectivity. J Biotechnol. 2010;145:199–205.
Alfonso V, Maroniche GA, Reca SR, Lopez MG, del Vas M, Taboga O. AcMNPV core gene ac109 is required for budded virion transport to the nucleus and for occlusion of viral progeny. PLoS ONE. 2012;7:e46146.
Amalfi S, Plastine MDP, López MG, Gravisaco MJ, Taboga O, Alfonso V. P26 enhances baculovirus gene delivery by modulating the mammalian antiviral response. Appl Microbiol Biotechnol. 2023;107:6277–86.
Dewey RA, Morrissey G, Cowsill CM, Stone D, Bolognani F, Dodd NJ, et al. Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials. Nat Med. 1999;5:1256–63.
Hopkins R, Esposito D. A rapid method for titrating baculovirus stocks using the Sf-9 Easy Titer cell line. Biotechniques. 2009;47:785–8.
Whitt MA, Manning JS. A phosphorylated 34-kDa protein and a subpopulation of polyhedrin are thiol linked to the carbohydrate layer surrounding a baculovirus occlusion body. Virology. 1988;163:33–42.
Wang S, Fang L, Fan H, Jiang Y, Pan Y, Luo R, et al. Construction and immunogenicity of pseudotype baculovirus expressing GP5 and M protein of porcine reproductive and respiratory syndrome virus. Vaccine. 2007;25:8220–7.
Park SW, Lee HK, Kim TG, Yoon SK, Paik SY. Hepatocyte-specific gene expression by baculovirus pseudotyped with vesicular stomatitis virus envelope glycoprotein. Biochem Biophys Res Commun. 2001. https://doi.org/10.1006/bbrc.2001.6009.
Yamagishi J, Burnett ED, Harwood SH, Blissard GW. The AcMNPV pp31 gene is not essential for productive AcMNPV replication or late gene transcription but appears to increase levels of most viral transcripts. Virology. 2007;365:34–47.
Fujita R, Matsuyama T, Yamagishi J, Sahara K, Asano S, Bando H. Expression of Autographa californica multiple nucleopolyhedrovirus genes in mammalian cells and upregulation of the host beta-actin gene. J Virol. 2006;80:2390–5.
Kitajima M, Hamazaki H, Miyano-Kurosaki N, Takaku H. Characterization of baculovirus Autographa californica multiple nuclear polyhedrosis virus infection in mammalian cells. Biochem Biophys Res Commun. 2006;343:378–84.
Mangor JT, Monsma SA, Johnson MC, Blissard GW. A GP64-null baculovirus pseudotyped with vesicular stomatitis virus G protein. J Virol. 2001;75:2544–56.
Yoshida Y, Emi N, Hamada H. VSV-G-pseudotyped retroviral packaging through adenovirus-mediated inducible gene expression. Biochem Biophys Res Commun. 1997;232:379–82.
Yang Y, Vanin EF, Whitt MA, Fornerod M, Zwart R, Schneiderman RD, et al. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Hum Gene Ther. 1995;6:1203–13.
Ernst W, Grabherr R, Wegner D, Borth N, Grassauer A, Katinger H. Baculovirus surface display: construction and screening of a eukaryotic epitope library. Nucleic Acids Res. 1998;26:1718–23.
Mäkelä AR, Matilainen H, White DJ, Ruoslahti E, Oker-Blom C. Enhanced baculovirus-mediated transduction of human cancer cells by tumor-homing peptides. J Virol. 2006;80:6603–11.
Yang D-G, Chung YC, Lai YK, Lai CW, Liu HJ, Hu YC. Avian influenza virus hemagglutinin display on baculovirus envelope: cytoplasmic domain affects virus properties and vaccine potential. Mol Ther. 2007;15:989–96.
Grabherr R, Ernst W, Doblhoff-Dier O, Sara M, Katinger H. Expression of foreign proteins on the surface of Autographa californica nuclear polyhedrosis virus. Biotechniques. 1997;22:730–5.
Acknowledgements
MGL, OT and VA are researchers from CONICET. MPP has a fellowship from ANPCyT.
Funding
This work was supported by Fondo Nacional de Ciencia y Tecnología (FONCyT), grant numbers PICT 3891 and PICT 0268, CONICET, PIP 592 and INTA, 2019-PD-E5-I105-001.
Author information
Authors and Affiliations
Contributions
Conceptualization, OT and VA; Methodology, MJG, MGL and VA; Investigation, MPP and SA; Writing – Original Draft, MPP, SA and VA; Writing – Review & Editing, MGL, OT and VA; Funding Acquisition, OT and VA; Supervision, VA.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Plastine, M.d.P., Amalfi, S., López, M.G. et al. Development of a stable Sf9 insect cell line to produce VSV-G pseudotyped baculoviruses. Gene Ther 31, 187–194 (2024). https://doi.org/10.1038/s41434-024-00442-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41434-024-00442-4